HDAC
HDAC(组蛋白去乙酰化酶)
Histone deacetylases (HDACs), known for their ability to target histones as well as more than 50 non-histone proteins, are classified into three major classes according to their homology to yeast proteins, including class I (HDAC1, HDAC2, HDAC3 and HDAC8), class II (HDAC4, HDAC5, HDAC7 and HDAC9) and class IV (HDAC11). HDAC inhibitors, a large group of compounds that is able to induce the accumulation of acetylated histones as well as non-histone proteins, are divided into several structural classes including hydroxamates, cyclic peptides, aliphatic acids and benzamides. HDAC inhibitors have been investigated for their efficacy as anticancer agents in the treatment of a wild range of cancers.
HDAC 相关产品(175)
- GC10839Tubastatin ACAS: 1252003-15-8纯度: >98.00%
Tubastatin A 是一种有效的选择性 HDAC6 抑制剂,IC 50 值为 15 nM。并且Tubastatin A也是一种新型GPX4抑制剂,Tubastatin A 直接与 GPX4 结合,诱导乳腺癌细胞铁死亡。
- GC11334Romidepsin (FK228, depsipeptide)CAS: 128517-07-7纯度: >99.50%
Romidepsin (FK228, depsipeptide)是一种有效且选择性的组蛋白去乙酰化酶(HDAC)抑制剂,抑制HDAC1,HDAC2,HDAC4和HDAC6的IC 50 值分别为36nM,47nM,510nM和1.4μM。
- GC11625Entinostat (MS-275,SNDX-275)CAS: 209783-80-2纯度: >99.00% / >98.00%
Entinostat (MS-275,SNDX-275)是一种强效的、可口服的组蛋白去乙酰化酶(HDACs)抑制剂,对HDAC1和HDAC3的IC₅₀分别为0.368μM和0.501μM,但对HDAC8的抑制作用相对较弱。
- GC12257Panobinostat (LBH589)CAS: 404950-80-7纯度: >99.00%
Panobinostat (LBH589)是一种强效,且具有口服活性和抗肿瘤活性的广谱组蛋白去乙酰化酶(HDAC)抑制剂,IC 50 值为5nM。
- GC14340TasquinimodCAS: 254964-60-8纯度: >98.00%
Tasquinimod是一种具有口服活性的组蛋白去乙酰化酶4(HDAC4)和S100 钙结合蛋白A9(S100A9)抑制剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10322 | Tubastatin A HCl | 1310693-92-5 | >98.00% | |
A potent HDAC6 inhibitor | ||||
| GC10423 | RG2833 | 1215493-56-3 | >98.00% | |
An HDAC inhibitor | ||||
| GC10839 | Tubastatin A | 1252003-15-8 | >98.00% | |
Tubastatin A 是一种有效的选择性 HDAC6 抑制剂,IC 50 值为 15 nM。并且Tubastatin A也是一种新型GPX4抑制剂,Tubastatin A 直接与 GPX4 结合,诱导乳腺癌细胞铁死亡。 | ||||
| GC11095 | Pyroxamide | 382180-17-8 | >99.50% | |
A HDAC inhibitor | ||||
| GC11334 | Romidepsin (FK228, depsipeptide) | 128517-07-7 | >99.50% | |
Romidepsin (FK228, depsipeptide)是一种有效且选择性的组蛋白去乙酰化酶(HDAC)抑制剂,抑制HDAC1,HDAC2,HDAC4和HDAC6的IC 50 值分别为36nM,47nM,510nM和1.4μM。 | ||||
| GC11424 | Valproic acid | 99-66-1 | >98.00% | |
A class I HDAC inhibitor | ||||
| GC11625 | Entinostat (MS-275,SNDX-275) | 209783-80-2 | >99.00% / >98.00% | |
Entinostat (MS-275,SNDX-275)是一种强效的、可口服的组蛋白去乙酰化酶(HDACs)抑制剂,对HDAC1和HDAC3的IC₅₀分别为0.368μM和0.501μM,但对HDAC8的抑制作用相对较弱。 | ||||
| GC11975 | CHAPS | 75621-03-3 | >99.00% | |
CHAPS 是胆酸的衍生物,是一种用于溶解膜蛋白的两性离子去污剂。 | ||||
| GC12019 | TCS HDAC6 20b | 956154-63-5 | - | |
An HDAC6 inhibitor | ||||
| GC12115 | CUDC-907 | 1339928-25-4 | >99.50% | |
CUDC 是一种口服生物可利用的小分子 PI3K 和 HDAC 双重抑制剂,作用于 PI3K α 和 HDAC1 / 2 / 3 / 10,IC50 分别为 19 nm 和 1.7 nm / 5 nm / 1.8 nm / 2.8 nm .在 WSU DLCL2 细胞中评估了双功能 HDAC 和 PI3K 抑制剂 CUDC-907 的抗肿瘤活性。 | ||||
| GC12257 | Panobinostat (LBH589) | 404950-80-7 | >99.00% | |
Panobinostat (LBH589)是一种强效,且具有口服活性和抗肿瘤活性的广谱组蛋白去乙酰化酶(HDAC)抑制剂,IC 50 值为5nM。 | ||||
| GC12961 | Apicidin | 183506-66-3 | >98.00% / >90.00% | |
A cell-permeable HDAC inhibitor | ||||
| GC13055 | Mocetinostat (MGCD0103, MG0103) | 726169-73-9 | >99.00% | |
An orally available HDAC inhibitor | ||||
| GC13237 | LMK 235 | 1418033-25-6 | >99.50% | |
A selective inhibitor of HDAC4 and HDAC5 | ||||
| GC13408 | CI994 (Tacedinaline) | 112522-64-2 | >98.00% | |
An inhibitor of HDAC1, -2, and -3 | ||||
| GC13435 | KD 5170 | 940943-37-3 | - | |
An inhibitor of class I and II HDACs | ||||
| GC13591 | TC-H 106 | 937039-45-7 | >98.00% | |
A tight-binding inhibitor of class I HDACs | ||||
| GC13706 | Droxinostat | 99873-43-5 | >99.50% | |
An inhibitor of HDAC3, HDAC6, and HDAC8 | ||||
| GC14243 | Resminostat hydrochloride | 1187075-34-8 | >99.00% | |
An orally bioavailable HDAC inhibitor | ||||
| GC14285 | RGFP966 | 1357389-11-7 | >99.50% / >98.00% | |
RGFP966是一种N-(o-aminophenyl)carboxamide HDAC抑制剂,对HDAC3的IC50为0.08 μM,是一类针对HDAC3的慢开/慢关竞争性紧密结合抑制剂。 | ||||
| GC14340 | Tasquinimod | 254964-60-8 | >98.00% | |
Tasquinimod是一种具有口服活性的组蛋白去乙酰化酶4(HDAC4)和S100 钙结合蛋白A9(S100A9)抑制剂。 | ||||
| GC14590 | AR-42 (OSU-HDAC42) | 935881-37-1 | - | |
HDAC inhibitor,novel and potent | ||||
| GC14682 | PCI-24781 (CRA-024781) | 783355-60-2 | >98.50% | |
An HDAC inhibitor | ||||
| GC14998 | Rocilinostat (ACY-1215) | 1316214-52-4 | >98.00% | |
A selective inhibitor of HDAC6 | ||||
